Sotabase

Career

· Founder, Better Engines2025–
· Consultant, Cognition All the Way Up (John Templeton Foundation funded project)2025–
· Researcher (Former Postdoctoral Scholar, Former Lecturer), UC Berkeley School of Information
· Research Assistant, University of Cambridge (Leverhulme Centre for the Future of Intelligence)

Publications (73)

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.
2017
347
cited
SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection.
New England Journal of Medicine · 2022
321
cited
Prospective, randomized, double‐blind, Phase 2 dose‐ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections
Journal of Antimicrobial Chemotherapy · 2017
135
cited
Colistin Monotherapy versus Combination Therapy for Carbapenem-Resistant Organisms.
NEJM Evidence · 2022
102
cited
Literary Event Detection
Annual Meeting of the Association for Computational Linguistics · 2019
94
cited
COVID-19 seropositivity and asymptomatic rates in healthcare workers are associated with job function and masking
Clinical Infectious Diseases · 2020
68
cited
Neutropenia during HIV Infection: Adverse Consequences and Remedies
International Reviews of Immunology · 2014
67
cited
Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical Trial
Journal of the American Medical Association (JAMA) · 2018
61
cited
Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection
JAMA Network Open · 2023
57
cited
Infections Associated with Use of Ultrasound Transmission Gel: Proposed Guidelines to Minimize Risk
Infection control and hospital epidemiology · 2012
45
cited
Multicenter Evaluation of the Unyvero Platform for Testing Bronchoalveolar Lavage Fluid
Journal of Clinical Microbiology · 2020
43
cited
SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent Clostridioides difficile Infection (rCDI)
Antibiotics · 2022
42
cited
The Emperor’s New Clothes: Prospective Observational Evaluation of the Association between the Day 2 Vancomycin Exposure and Failure Rates among Adult Hospitalized Patients with MRSA Bloodstream Infections (PROVIDE)
Open Forum Infectious Diseases · 2017
36
cited
A multiplex polymerase chain reaction assay for antibiotic stewardship in suspected pneumonia☆☆☆☆☆☆
Diagnostic microbiology and infectious disease · 2020
35
cited
Pharmacokinetic and Pharmacodynamic Profiling of Minocycline for Injection following a Single Infusion in Critically Ill Adults in a Phase IV Open-Label Multicenter Study (ACUMIN)
Antimicrobial Agents and Chemotherapy · 2020
33
cited
Antimicrobial susceptibility assays based on the quantification of bacterial lipopolysaccharides via a label free lectin biosensor.
Analytical Chemistry · 2015
29
cited
An Outbreak of Pseudomonas aeruginosa Respiratory Tract Infections Associated with Intrinsically Contaminated Ultrasound Transmission Gel
Infection Control & Hospital Epidemiology · 2013
28
cited
Extended Follow-up of Microbiome Therapeutic SER-109 Through 24 Weeks for Recurrent Clostridioides difficile Infection in a Randomized Clinical Trial.
Journal of the American Medical Association (JAMA) · 2022
27
cited
Measuring Information Propagation in Literary Social Networks
Conference on Empirical Methods in Natural Language Processing · 2020
25
cited
PROPHETIC: Prospective Identification of Pneumonia in Hospitalized Patients in the Intensive Care Unit.
Chest · 2020
23
cited
Sotabase
Matthew Sims | Researcher Profile | Sotabase | Sotabase